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Introduction
Idiopathic orbital inflammation is an idiopathic benign
inflammatory space-occupying lesion (1). Presenting symp-
toms include proptosis, oculomotor deficits, pain, lid swel-
ling or mass, ptosis, and chemosis. The disease progression
of idiopathic orbital inflammation can be acute to subacute
or occasionally chronic and idiopathic orbital inflammation
is usually unilateral but may occasionally be bilateral. A
small subset of patients may have decreased visual acuity
because of optic nerve compression (2). It has recently been
suggested that idiopathic orbital inflammation is one of the
components of IgG4-related disease (3-6). IgG4-related dis-
ease is characterized by dense infiltration of IgG4-positive
plasma cells into multiple organs or tissues in association
with increased serum levels of IgG4 (>135 mg/dl). This
disorder is frequently seen in older males, often older males
with allergic disorders, and the most common organs in-
volved are the salivary glands and pancreas. Among the en-
docrine organs, the pituitary gland (7, 8) and the thyroid (9)
have been shown to be affected.
Here we present a patent with marked proptosis and
compressive optic neuropathy putatively caused by IgG4-
related idiopathic orbital inflammation with positive TSH
receptor-stimulating antibodies.
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Case Report
A case of compressive optic neuropathy putatively caused by IgG4-related
idiopathic orbital inflammation.
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We report the case of a 58-year-old male presenting with an impairment of the left-sided visual acuity caused by compres-
sive optic neuropathy, and marked bilateral proptosis. Blood test showed markedly elevated IgG4 (1830 mg/dl) and positive
TSH receptor-stimulating antibodies (200%), but the thyroid function test were normal. Orbital MRI revealed abnormal soft tis-
sue proliferation around the optic nerve and fusiform enlargement of the extraocular muscles. Systemic CT analysis detected
multiple lymph node swelling, pseudotumor in the lung, retroperitoneal fibrosis, and kidney lesions. We considered that the eye
manifestation was most likely caused by IgG4-related idiopathic orbital inflammation. Systemic administration of a moderate
dose of prednisolone dramatically improved the compression of the optic nerve, as shown by the improvement of the visual
acuity and the MRI findings. The clinical course made thyroid-associated ophthalmopathy unlikely. In conclusion, an overall
consideration of the clinical picture and extensive work-up of any possible differential diagnosis including measurement of the
serum levels of IgG4 was highly useful in making the diagnosis of the patient.
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Patient
A 58-year-old male smoker was referred to our hospital
due to reduced visual acuity and bilateral proptosis. He had
no allergic diathesis and no family history of thyroid disor-
ders. He had had proptosis of the left eye for three years
and had had glucocorticoids treatment with prednisolone
starting from 30 mg per day for compressive optic neuropathy
two years before the referral. There had been clinical im-
provement of proptosis and the visual acuity, but the patient
terminated prednisolone by himself and then noticed grad-
ual aggravation of proptosis and impairment of the visual
acuity.
On physical examination, there was marked proptosis
(35 mm, bilaterally, determined by an exophthalmometer)
with intact eyeball movement. His visual acuity was 20/30
after correction and hand motion at 30 cm in the right and
left eye, respectively. There were no enlarged thyroid or
palpable superficial lymph nodes and no skin lesions iden-
tified. Ophthalmologic investigation did not reveal any signs
suggestive of uveitis. Blood test revealed mild eosinophilia
(10% of 8500 white blood cells /uL) and a marked increase
of total protein (10.5 g/dl). Serum levels of IgG and IgE
were increased to 4940 mg/dl (reference range 879-1700
mg/dl) and 1765.6 mg/dl (reference range <269 mg/dl),
respectively. There was no monoclonal immunoglobulin.
Subclass analysis of serum IgG disclosed a marked in-
creased in IgG4 to 1830 mg/dl (>135 mg/dl being consid-
ered abnormally high (10, 11)). The serum level of soluble
IL-2 receptor was increased (1463 U/ml; reference range
124-466 U/ml). Proteinase 3- and myeloperoxidase-anti-
neutrophil cytoplasmic antibodies were negative. Thyroid
function was normal: free T3 3.15 pg/ml (2.37-3.91 pg/ml),
free T4 1.28 ng/dl (0.95-1.57 ng/dl), and TSH 4.044
uIU/mL (0.48-5.08 uIU/mL); however, TSH receptor-
stimulating antibodies were 200% (<180%) and positive.
The orbital MRI (Figure 1A and B) showed proliferation of
aberrant soft tissue in both sides of the orbit and mild en-
largement of the extraocular muscles.
The marked elevation of serum IgG4 suggested IgG4-
related idiopathic orbital inflammation. Since IgG4-related
disease is known to show systemic involvement, we inves-
tigated putative lesions caused by IgG4-related disease by
whole body CT. We were able to identify a lung pseudotumor,
retroperitoneal fibrosis, and multiple less enhanced areas in
the bilateral kidneys as well as swollen LNs from the neck to
the mediastinum (not shown). Positron emission tomography-
CT also documented fluorodeoxyglucose accumulation in
the bilateral orbits, nasal sinus, mediastinal and hilar lymph
nodes and lung pseudotumor. Since the patient refused a
tissue biopsy or surgical decompression of the left optic
nerve, we were not able to make a definitive diagnosis.
Considering the organs affected and the high levels of serum
IgG4 and soluble IL-2 receptor, Wegener's granulomatosis
and malignant lymphoma were the most important differen-
tial diagnoses. Wegener's granulomatosis was unlikely be-
cause of the negative anti-neutrophil cytoplasmic antibod-
ies. His previous medical history of improvement of the
visual acuity and proptosis by a moderate dose of prednisolone
made malignant lymphoma unlikely. Based on the typical
clinical findings, we considered that a diagnosis of IgG4-
related disease including idiopathic orbital inflammation was
most likely.
It was apparent that IgG4-related idiopathic orbital in-
flammation was the major element causing the proptosis
and compressive optic neuropathy (Figure 1A and B), and
thus the patient was treated with 20 mg of prednisolone.
There was gradual improvement of the visual acuity (20/30
after correction and 20/1000 in the right and left eye, re-
spectively) and dramatic amelioration of proptosis (17 mm,
bilaterally), and there was also a decrease in the serum lev-
els of IgG4 (468 mg/dl) and soluble IL-2 receptor (~500
U/ml). The aberrant orbital soft tissue dramatically declined
and the extraocular muscles became slightly reduced in size
(Figure 1C and D), and similar improvements in the lung
and kidney were also noted in the follow-up CT (not
shown). Therefore, the dose of prednisolone was tapered
gradually down to 10 mg per day. However, there was
symptomatic aggravation of the visual acuity shortly after
the reduction of prednisolone. Therefore, a final mainte-
nance dose of 13 mg was used, and resulted in no apparent
relapse of the clinical symptoms.
Discussion
IgG4-related disease is an emerging disease concept in
which the affected organs or tissues may become tumorous
as a result of a chronic inflammatory process, including
IgG4-positive cell infiltration associated with fibrosis (10,
11). IgG4-related idiopathic orbital inflammation can occur
alone or in association with other organ manifestation. The
precise mechanism(s) by which IgG4-related disease devel-
ops have not been elucidated. It has been reported that
IgG4 concentrations are closely associated with disease ac-
tivity in IgG4-related disease (12). However, it is not
known whether IgG4 has any pathogenic roles in IgG4-
related disease. It has been shown that allergic rhinitis and
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bronchial asthma are frequently associated with IgG4-related
disease (10). The allergic aspect of IgG4-related disease
may be further supported by the fact that a moderate dose
of glucocorticoids has a favorable therapeutic response.
Thyroid-associated ophthalmopathy (TAO) is the major
cause of proptosis seen in individuals suffering from Graves
disease. TAO can develop in euthyroid patients without con-
current or previous history of Graves disease, but thyrotropin
receptor autoantibodies are generally present in the sera of
most such patients. In addition, increased volume of the or-
bital adipose tissue and/or extraocular muscles as retro-
ocular alterations on CT and MRI are also always seen in
patients with TAO (13). Several potential mechanisms have
been put forward to explain the pathogenesis of TAO, in-
cluding thyrotropin receptor autoantibodies and anti-insulin
like growth factor-1 receptor autoantibodies interacting
with its cognate receptor expressing in the orbital fibroblast
(13). These findings support the idea of an autoimmune
pathogenesis of TAO. Treatment of severe TAO consists of
a high dose of glucocorticoids including steroid pulse
therapy with or without external beam radiation to the
retro-orbital space, occasionally followed by surgery (14).
Our patient reported herein showed the favorable clinical
response to the moderate dose of prednisolone and, there-
fore, it was highly unlikely that TAO was the major com-
ponent in making the extraocular muscle enlarged. This no-
tion was also supported by the fact that TSH receptor-
stimulating antibodies seen in our patient was only
marginally positive and, therefore, too low to develop TAO
since the levels of TSH receptor antibodies have been
shown a tendency to correlate with the severity of TAO
(15). Thus, positive TSH receptor-stimulating antibodies
seen in our patient were, most likely, not more than coinci-
dental. Although a clinical association between TAO and
IgG4-related idiopathic orbital inflammation has not been
reported so far, it is intriguing to consider that IgG4-related
idiopathic orbital inflammation can expand and involve the
orbital tissues, releasing the TSH receptor autoantigen lo-
cally which in turn generates the autoantibodies to the TSH
receptor.
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Figure 1. Ocular MRI before and after prednisolone treatment.
Panels (A) and (B) show massive proliferation of soft tissue around the optic nerve adjoining the
extraocular muscles. The extraocular muscles show fusiform enlargement relatively sparing the ten-
dons in the left eye. The soft tissue proliferation and extraocular muscle enlargement in the right
eye are less prominent. There is also the marked mucosal thickening in the nasal sinus as well as
the soft tissue swelling around the infraorbital nerves. Panels (C) and (D) show orbital MRI images
obtained one month after prednisolone treatment. The dramatic reduction of the proliferating soft
tissue in both the eyes and nasal mucosa was noteworthy, as well as the slight improvement of the
extraocular muscle enlargement. T1-weighted images of the axial section are shown in panels (A)
and (C) and T2-weighted images of the coronal section are shown in (B) and (D).
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Here we reported a patient with compressive optic
neuropathy and marked proptosis caused by IgG4-related
idiopathic orbital inflammation with positive TSH receptor-
stimulating antibodies. This case suggests an importance of
overall consideration of the clinical picture and extensive
work-up of any possible differential diagnosis.
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